Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1643069

registered interest
date	08/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer and Radiology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has made recent representations made to (a) the Chancellor of the Exchequer and (b) NHS England on investment in the clinical (i) radiology and (ii) oncology workforce.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	188505
answer	answer is ministerial correction date of answer 14/06/2023 answer text <p>The Secretary of State for Health and Social Care meets regularly with other Cabinet colleagues and with NHS England to discuss issues relating to the National Health Service workforce.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 14/06/2023 14:00:35 answering member 4527 label Biography information for Helen Whately
tabling member	3960 label Biography information for Henry Smith

1628301

registered interest
date	16/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Advanced Therapy Medicinal Products
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	185240
answer	answer is ministerial correction date of answer 25/05/2023 answer text <p>The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE’s processes for evaluating ATMPs.</p><p> </p><p>NICE’s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.</p> answering member constituency Colchester answering member printed Will Quince question first answered 25/05/2023 12:35:12 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1628302

registered interest
date	16/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gene Therapies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential support for UK leadership in the adoption of cell and gene therapies of the recommendations of the Cell and Gene Therapy Catapult’s National Cell and Gene Therapy Vision for the UK, published in March 2022.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	185241
answer	answer is ministerial correction date of answer 23/05/2023 answer text <p>The Department recognises that advanced cell and gene therapies will be an important part of the future of healthcare and the life sciences industry. We have been considering the recommendations of the Cell and Gene Therapy Catapult’s ‘National Cell and Gene Therapy Vision for the UK’, a report published by the Cell and Gene Therapy Catapult in March 2022 and the UK Strategic Stem Cell Forum’s latest report ‘A 10-year vision for stem cell transplantation and cellular therapies’ published in July 2022.</p><p>As part of this, we have been conducting stakeholder engagement to further understand the challenges raised and whether there is a role for the Department in coordinating activity in this area.</p> answering member constituency Colchester answering member printed Will Quince question first answered 23/05/2023 15:10:28 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586244

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he will make an assessment of the impact of the removal of healthcare products and devices from the market due to price increase applications being rejected by NHS Supply Chains on the users of those products.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146880
answer	answer is ministerial correction date of answer 27/02/2023 answer text <p>NHS Supply Chain (NHSSC) has robust measures in place to monitor supply chains and works closely with markets to ensure continuity of supply, so that the National Health Service has the medical devices and clinical consumables it needs to deliver care. Given the economic environment and global inflationary pressures, NHS Supply Chain recognises the challenges that suppliers are facing and is committed to working with them within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>An established process exists for all price increase requests. These are evaluated by NHSSC on a case-by-case basis in line with the terms and conditions of awarded framework agreements. In order for an increase to be accepted, it needs to be justified and evidenced, and suppliers are expected to play their part in mitigating their cost pressures.</p><p> </p><p>With specific reference to energy costs, the Government remains committed to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 146881 146882 question first answered 27/02/2023 13:56:33 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586245

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to support UK businesses that supply the NHS with medical devices, medical equipment and services impacted by additional costs relating to (a) production, (b) distribution and (c) energy.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146881
answer	answer is ministerial correction date of answer 27/02/2023 answer text <p>NHS Supply Chain (NHSSC) has robust measures in place to monitor supply chains and works closely with markets to ensure continuity of supply, so that the National Health Service has the medical devices and clinical consumables it needs to deliver care. Given the economic environment and global inflationary pressures, NHS Supply Chain recognises the challenges that suppliers are facing and is committed to working with them within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>An established process exists for all price increase requests. These are evaluated by NHSSC on a case-by-case basis in line with the terms and conditions of awarded framework agreements. In order for an increase to be accepted, it needs to be justified and evidenced, and suppliers are expected to play their part in mitigating their cost pressures.</p><p> </p><p>With specific reference to energy costs, the Government remains committed to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 146880 146882 question first answered 27/02/2023 13:56:33 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586246

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Supply Chains
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to support UK-based NHS suppliers with increases in costs and supply chain pressures.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146882
answer	answer is ministerial correction date of answer 27/02/2023 answer text <p>NHS Supply Chain (NHSSC) has robust measures in place to monitor supply chains and works closely with markets to ensure continuity of supply, so that the National Health Service has the medical devices and clinical consumables it needs to deliver care. Given the economic environment and global inflationary pressures, NHS Supply Chain recognises the challenges that suppliers are facing and is committed to working with them within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>An established process exists for all price increase requests. These are evaluated by NHSSC on a case-by-case basis in line with the terms and conditions of awarded framework agreements. In order for an increase to be accepted, it needs to be justified and evidenced, and suppliers are expected to play their part in mitigating their cost pressures.</p><p> </p><p>With specific reference to energy costs, the Government remains committed to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 146880 146881 question first answered 27/02/2023 13:56:33 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1586247

registered interest
date	17/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Equipment: Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to support UK businesses that supply the NHS with medical devices, medical equipment and services impacted by additional costs in relating to (a) production, (b) distribution and (c) energy.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	146883
answer	answer is ministerial correction date of answer 02/03/2023 answer text <p>The Department and NHS Supply Chain (NHSSC) recognise challenges faced by suppliers relating to the economic environment and global inflationary pressures. The Government and NHSSC remain committed to working with suppliers within the bounds of contractual agreements, to secure value for money for taxpayers and maintain availability.</p><p> </p><p>With specific reference to energy costs, the Government is dedicated to supporting businesses via the Energy Bill Relief Scheme which provides a discount on the wholesale element of gas and electricity bills to ensure that eligible non-domestic customers are protected from excessively high energy costs over the winter period. Following an HM Treasury led review, the new Energy Bill Discount Scheme will run from April until March 2024 and continue to provide a discount to eligible non-domestic customers.</p> answering member constituency Colchester answering member printed Will Quince question first answered 02/03/2023 16:56:17 answering member 4423 label Biography information for Will Quince
tabling member	3960 label Biography information for Henry Smith

1580829

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cardiovascular Diseases and Cholesterol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help prevent (a) high cholesterol (b) cardiovascular diseases; and whether he has made an assessment of the potential impact of inflation on the (a) prevalence and (b) treatment of those diseases.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	132380
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department is taking steps to prevent high cholesterol and cardiovascular disease (CVD) by taking forward a programme of work to modernise the NHS Health Check and ensure that as many people as possible benefit from this prevention programme. This includes developing a national digital NHS Health Check to complement the in-person service and enable people to self-check at home.</p><p>The National Health Service’s priorities for 2023/24 are set out in the NHS operational planning guidance. This includes objectives on preventing CVD by improving the management of hypertension and CVD risk. Primary Care Networks’ service requirements also include objectives to improve hypertension case-finding and diagnosis, diagnosis of familial hypercholesterolaemia and cholesterol management.</p><p>The Department has not assessed the potential impact of inflation on the prevalence and treatment of CVD.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 01/02/2023 12:16:42 answering member 4679 label Biography information for Neil O'Brien
tabling member	3960 label Biography information for Henry Smith

1580830

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Standards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 June 2022 to Question 21237 on Health Services: Standards, what progress he has made on reviewing that progress against the commitments relating to cardiovascular disease and cholesterol; whether those targets will not be removed from the updated NHS Long Term Plan; and if he will publish the updated NHS Long Term Plan in January 2023 at the latest.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	132381
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>Progress against cardiovascular disease (CVD) commitments in 2021-22 includes 56,000 more patients identified as having a 20% or greater 10-year risk of developing CVD being treated with lipid lowering therapies; 1.1 million more people had their hypertension controlled; and 46,000 more people with atrial fibrillation were treated with an anti-coagulant compared to 2020-21.</p><p>The National Health Service’s priorities for 2023-24 are set out in the NHS operational planning guidance, detailing an ongoing commitment to the goals of the NHS Long Term Plan, including those on cardiovascular disease. There are specific objectives in the guidance for improving the management of people with hypertension and high cholesterol.</p><p>The Hewitt review is currently looking at the scope and options for national targets and how to empower local leaders to improve outcomes for their populations and the Department looks forward to considering its conclusions.</p><p>As the Secretary of State announced on 24 January, the Department is developing a strategy for major conditions, including cardiovascular disease, with an interim report due summer 2023. This will build on the commitments already made in the NHS Long Term Plan.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 01/02/2023 12:18:10 answering member 4679 label Biography information for Neil O'Brien
tabling member	3960 label Biography information for Henry Smith

1579609

registered interest
date	23/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Weather: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to investigate the reasons for the increase in excess deaths over winter 2022/23.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	129759
answer	answer is ministerial correction date of answer 27/01/2023 answer text <p>The Office for Health Improvement and Disparities produces a monthly update of excess mortality statistics, which have been used to monitor excess deaths since July 2020 and adjust for age and size of the population. There are a range of different organisations producing different estimates based on different methodologies.</p><p> </p><p>It is likely that a combination of factors has contributed to excess deaths over winter 2022/23, including high flu prevalence, cold, the ongoing challenges of COVID-19 and health conditions such as heart disease and diabetes.</p><p>We are taking steps to help reduce excess deaths, including those which involve COVID-19, and those due to other factors.</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 27/01/2023 10:39:28 answering member 4679 label Biography information for Neil O'Brien
tabling member	3960 label Biography information for Henry Smith